| Lauren Michal Moyer, LCSW | |
|
3100 Martin Luther King Jr Pkwy, Springfield, OR 97477-7514 | |
| (541) 868-9700 | |
| (541) 485-7392 |
| Full Name | Lauren Michal Moyer |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 10 Years |
| Location | 3100 Martin Luther King Jr Pkwy, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831404482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | L7161 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Care Pc | 8820986458 | 32 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
The Phase 2 study was a randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of MBX-8025, both alone and in combination with atorvastatin (marketed as Lipitor(R)), over an 8-week treatment period.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (ZYTIGA) plus prednisone showed a statistically significant improvement in radiographic progression-free survival (rPFS) and all secondary endpoints compared to patients treated with placebo plus prednisone.
XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.
› Verified 1 days ago
| Entity Name | Womens Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250044 PECOS PAC ID: 8820986458 Enrollment ID: O20040305001026 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
The Phase 2 study was a randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of MBX-8025, both alone and in combination with atorvastatin (marketed as Lipitor(R)), over an 8-week treatment period.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (ZYTIGA) plus prednisone showed a statistically significant improvement in radiographic progression-free survival (rPFS) and all secondary endpoints compared to patients treated with placebo plus prednisone.
XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.
› Verified 1 days ago
| Entity Name | Center For Family Development, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265609184 PECOS PAC ID: 2466629217 Enrollment ID: O20120118000693 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
The Phase 2 study was a randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of MBX-8025, both alone and in combination with atorvastatin (marketed as Lipitor(R)), over an 8-week treatment period.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (ZYTIGA) plus prednisone showed a statistically significant improvement in radiographic progression-free survival (rPFS) and all secondary endpoints compared to patients treated with placebo plus prednisone.
XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Michal Moyer, LCSW 1258 High St, Eugene, OR 97401-3238 Ph: (541) 342-8437 | Lauren Michal Moyer, LCSW 3100 Martin Luther King Jr Pkwy, Springfield, OR 97477-7514 Ph: (541) 868-9700 |
News Archive
A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.
The Phase 2 study was a randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of MBX-8025, both alone and in combination with atorvastatin (marketed as Lipitor(R)), over an 8-week treatment period.
Rhythm control therapy for atrial fibrillation may improve survival rates compared with rate control therapy when used long term, show study results published in the Archives of Internal Medicine.
Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (ZYTIGA) plus prednisone showed a statistically significant improvement in radiographic progression-free survival (rPFS) and all secondary endpoints compared to patients treated with placebo plus prednisone.
XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.
› Verified 1 days ago
Warren Douglas Martin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2073 Olympic Street, Springfield, OR 97477 Phone: 541-682-3550 Fax: 541-682-3551 | |
Ms. Susan Margaret Trefts, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 946 E Street, Springfield, OR 97477 Phone: 541-852-0351 | |
Ms. Mary Jo Sanders, RN, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1651 Centennial Blvd, Springfield, OR 97477 Phone: 541-762-4551 | |
Stephanie A Simons, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1126 Gateway Loop Ste 140, Springfield, OR 97477 Phone: 541-654-8107 | |
Ms. Judith M. Green, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3995 Marcola Rd, Springfield, OR 97477 Phone: 541-726-1465 Fax: 541-726-5085 | |
Celia Rae Mansfield, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1126 Gateway Loop, Springfield, OR 97477 Phone: 541-670-5231 | |
Sarah Beth Mackenzie, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3995 Marcola Rd, Springfield, OR 97477 Phone: 541-689-3280 |